<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To describe the clinical outcomes and thrombotic events in a series of <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients positive for antiphospholipid (aPL) antibodies </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Retrospective case series study </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Medical-surgical oncologic intensive care unit (ICU) </plain></SENT>
<SENT sid="3" pm="."><plain>PATIENTS AND PARTICIPANTS: Eighteen patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SIRS</z:e>/<z:hpo ids='HP_0100806'>sepsis</z:hpo> and multiple organ failure (MOF) and positive for aPL antibodies, included over a 10-month period </plain></SENT>
<SENT sid="4" pm="."><plain>INTERVENTIONS: None MEASUREMENTS AND RESULTS: aPL antibodies and coagulation parameters were measured up to 48 hours after the occurrence of <z:hpo ids='HP_0001063'>acrocyanosis</z:hpo> or arterial/venous thrombotic events </plain></SENT>
<SENT sid="5" pm="."><plain>When current criteria for the diagnosis of aPL syndrome were applied, 16 patients met the criteria for 'probable' and two patients had a definite diagnosis of APL syndrome in its catastrophic form (CAPS) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001063'>Acrocyanosis</z:hpo>, arterial events and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> were present in eighteen, nine and five patients, respectively </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0100806'>Sepsis</z:hpo>, <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and major surgery were the main precipitating factors </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients developed MOF during the ICU stay, with a hospital mortality rate of 72% (13/18) </plain></SENT>
<SENT sid="9" pm="."><plain>Five patients were discharged from the hospital </plain></SENT>
<SENT sid="10" pm="."><plain>There were three survivors at 90 days of follow-up </plain></SENT>
<SENT sid="11" pm="."><plain>New measurements of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) antibodies were performed in these three survivors and one patient still tested positive for these antibodies </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: In this small series of patients, we observed a high frequency of auto-antibodies and micro- and macro-vascular thrombotic events in <z:e sem="disease" ids="C0010340" disease_type="Disease or Syndrome" abbrv="">critically ill</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="13" pm="."><plain>The coexistence of <z:hpo ids='HP_0100806'>sepsis</z:hpo> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SIRS</z:e> and aPL antibodies was often associated with MOF and <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="14" pm="."><plain>More studies are necessary to determine the pathophysiological significance of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in severely ill <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
</text></document>